Dr. Yasuhiro Nagai, Director of Preclinical Development, will present a poster regarding the efficacy and mechanism of action of UI-102, a TLR7/8 agonist encapsulated in United Immunity's Pullulan Nanoparticle (PNP) for the treatment of solid tumors during the AACR Annual Meeting that will take place on April 17 - 22, 2026 in San Diego.
Poster Presentation Details:
Title: UI-102: A novel M2-like TAM-targeted nanoparticulate TLR7/8 agonist
Poster Number: 447
Date and Time: Sunday, April 19, 2026, 2:00PM - 5:00 PM
Session Category: Novel Therapeutics and Drug Targets 1
Location: Poster Section 18, Poster Board Number: 17
For more information and to view the company’s abstract, please visit the AACR Annual Meeting website: www.aacr.org/meeting/aacr-annual-meeting-2026/